Table 2.
Serum clusterin concentrations in ESCC patients and healthy individuals.
| Variable | Number | Concentration (μg/mL) | P value |
|---|---|---|---|
| ESCC patients | 87 | 412.3 ± 159.4 | <0.0001* |
| Healthy individuals | 136 | 288.8 ± 75.1 | |
| ESCC patients (excluding smoker) | 30 | 419.4 ± 154.2 | <0.0001* |
| Healthy individuals | 136 | 288.8 ± 75.1 | |
| ESCC patients (excluding drinker) | 45 | 413.3 ± 141.9 | <0.0001* |
| Healthy individuals | 136 | 288.8 ± 75.1 | |
| ESCC patients (excluding diabetes patients) | 80 | 416.3 ± 164.1 | <0.0001* |
| Healthy individuals | 136 | 288.8 ± 75.1 | |
| ESCC patients (excluding cardiovascular diseases patients) | 73 | 406.88 ± 167.7 | <0.0001* |
| Healthy individuals | 136 | 288.8 ± 75.1 | |
| ESCC patients (excluding all confounders) | 17 | 400.5 ± 176.2 | 0.0028* |
| Healthy individuals | 136 | 288.8 ± 75.1 |
ESSC: esophageal squamous cell carcinoma.
*The P value describes the difference in serum clusterin concentration between the samples from the ESCC patients and those from the healthy controls. Significance was determined by independent-samples Mann-Whitney U test.